The California Department of Justice mandate to consult CURES (Controlled Substance Utilization Review and Evaluation) prior to prescribing, ordering, administering, or furnishing a Schedule II, II or IV controlled substance becomes effective on October 2, 2018.
The law states that CURES must be consulted the first time a patient is prescribed, ordered or administered a Schedule II, III or IV controlled substance. CURES must be consulted every four months thereafter if the medication remains part of the patient’s treatment plan.
It is recommended that you document any reason that you do not consult CURES.
Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Find out how.
